BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $544.09 million. The enterprise value is $482.44 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, before market open.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 36.66 million shares outstanding. The number of shares has increased by 21.96% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 36.66M |
| Shares Change (YoY) | +21.96% |
| Shares Change (QoQ) | +7.02% |
| Owned by Insiders (%) | 16.28% |
| Owned by Institutions (%) | 23.60% |
| Float | 22.88M |
Valuation Ratios
The trailing PE ratio is 71.28 and the forward PE ratio is 44.25.
| PE Ratio | 71.28 |
| Forward PE | 44.25 |
| PS Ratio | 10.42 |
| Forward PS | 2.54 |
| PB Ratio | 7.43 |
| P/TBV Ratio | 7.43 |
| P/FCF Ratio | 33.44 |
| P/OCF Ratio | 30.19 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 82.31, with an EV/FCF ratio of 29.65.
| EV / Earnings | 63.20 |
| EV / Sales | 9.24 |
| EV / EBITDA | 82.31 |
| EV / EBIT | 111.60 |
| EV / FCF | 29.65 |
Financial Position
The company has a current ratio of 3.83, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.83 |
| Quick Ratio | 3.24 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.16 |
| Debt / FCF | 0.42 |
| Interest Coverage | 1.96 |
Financial Efficiency
Return on equity (ROE) is 11.26% and return on invested capital (ROIC) is 45.78%.
| Return on Equity (ROE) | 11.26% |
| Return on Assets (ROA) | 2.61% |
| Return on Invested Capital (ROIC) | 45.78% |
| Return on Capital Employed (ROCE) | 4.76% |
| Weighted Average Cost of Capital (WACC) | 6.26% |
| Revenue Per Employee | $435,208 |
| Profits Per Employee | $63,608 |
| Employee Count | 120 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.22 |
Taxes
In the past 12 months, BrainsWay has paid $77,000 in taxes.
| Income Tax | 77,000 |
| Effective Tax Rate | 1.00% |
Stock Price Statistics
The stock price has increased by +184.29% in the last 52 weeks. The beta is 0.31, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +184.29% |
| 50-Day Moving Average | 12.48 |
| 200-Day Moving Average | 9.01 |
| Relative Strength Index (RSI) | 45.14 |
| Average Volume (20 Days) | 204,649 |
Short Selling Information
The latest short interest is 116,294, so 0.36% of the outstanding shares have been sold short.
| Short Interest | 116,294 |
| Short Previous Month | 101,072 |
| Short % of Shares Out | 0.36% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.60 |
Income Statement
In the last 12 months, BrainsWay had revenue of $52.23 million and earned $7.63 million in profits. Earnings per share was $0.18.
| Revenue | 52.23M |
| Gross Profit | 39.39M |
| Operating Income | 4.32M |
| Pretax Income | 7.71M |
| Net Income | 7.63M |
| EBITDA | 5.86M |
| EBIT | 4.32M |
| Earnings Per Share (EPS) | $0.18 |
Full Income StatementBalance Sheet
The company has $67.70 million in cash and $6.82 million in debt, with a net cash position of $60.88 million or $1.66 per share.
| Cash & Cash Equivalents | 67.70M |
| Total Debt | 6.82M |
| Net Cash | 60.88M |
| Net Cash Per Share | $1.66 |
| Equity (Book Value) | 73.22M |
| Book Value Per Share | 2.00 |
| Working Capital | 62.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $18.02 million and capital expenditures -$1.75 million, giving a free cash flow of $16.27 million.
| Operating Cash Flow | 18.02M |
| Capital Expenditures | -1.75M |
| Depreciation & Amortization | 1.54M |
| Net Borrowing | -832,000 |
| Free Cash Flow | 16.27M |
| FCF Per Share | $0.44 |
Full Cash Flow StatementMargins
Gross margin is 75.42%, with operating and profit margins of 8.28% and 14.62%.
| Gross Margin | 75.42% |
| Operating Margin | 8.28% |
| Pretax Margin | 14.76% |
| Profit Margin | 14.62% |
| EBITDA Margin | 11.22% |
| EBIT Margin | 8.28% |
| FCF Margin | 31.16% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.96% |
| Shareholder Yield | -21.96% |
| Earnings Yield | 1.40% |
| FCF Yield | 2.99% |
Analyst Forecast
The average price target for BrainsWay is $13.25, which is 5.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.25 |
| Price Target Difference | 5.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on March 4, 2026. It was a forward split with a ratio of 2:1.
| Last Split Date | Mar 4, 2026 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
